APA (7th ed.) Citation

Aloul, K. M., Nielsen, J. E., Defensor, E. B., Lin, J. S., Fortkort, J. A., Shamloo, M., . . . Barron, A. E. (2022). Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Frontiers in immunology, 13, 880961. https://doi.org/10.3389/fimmu.2022.880961

Chicago Style (17th ed.) Citation

Aloul, Karim M., Josefine Eilsø Nielsen, Erwin B. Defensor, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, Jeffrey D. Cirillo, Adrian F. Gombart, and Annelise E. Barron. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology 13 (2022): 880961. https://doi.org/10.3389/fimmu.2022.880961.

MLA (9th ed.) Citation

Aloul, Karim M., et al. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology, vol. 13, 2022, p. 880961, https://doi.org/10.3389/fimmu.2022.880961.